Case control study of psychosocial morbidity in beta thalassemia major

Area of Science:

• Pediatric Hematology
• Child Psychology
• Clinical Psychology

Background:

• Beta-thalassemia major is a chronic genetic blood disorder requiring lifelong treatment.
• Psychosocial well-being is a critical but often overlooked aspect of managing chronic childhood illnesses.
• Understanding the psychological impact on affected children is essential for holistic care.

Purpose of the Study:

• To determine the prevalence and range of psychosocial morbidity in children with beta-thalassemia major.
• To explore the relationship between psychosocial issues and social/disease-related factors in this population.
• To compare psychosocial health in children with beta-thalassemia major to a healthy control group.

Main Methods:

• A study group of 60 children (ages 5-15) with transfusion-dependent beta-thalassemia major was assessed.
• A control group of 60 age- and socially-matched children was included for comparison.
• Psychosocial morbidity was evaluated using semi-structured interviews and standardized questionnaires (PSC, CPMS).

Main Results:

• Children with beta-thalassemia major exhibited significantly higher mean scores on both the Pediatric Symptom Checklist (PSC) and Childhood Psychopathology Measurement Schedule (CPMS) compared to controls (P < .001).
• Over half (54%) of children with thalassemia showed scores indicative of psychopathological disorders, versus only 8.3% in the control group (P < .001).

Conclusions:

• Children diagnosed with beta-thalassemia major face a substantially increased burden of psychosocial morbidity.
• Psychosocial factors must be integrated into the comprehensive management plan for children with beta-thalassemia major.
• Early intervention for psychological distress can prevent the development of overt psychological diseases.